Works matching IS 13518216 AND DT 2024 AND VI 30 AND IP 5
Results: 23
Issue Information.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1105, doi. 10.1111/hae.15093
- Publication type:
- Article
Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1203, doi. 10.1111/hae.15089
- By:
- Publication type:
- Article
Driving improvement of diagnosis and awareness of heavy menstrual bleeding in women among physicians.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1185, doi. 10.1111/hae.15088
- By:
- Publication type:
- Article
Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1170, doi. 10.1111/hae.15087
- By:
- Publication type:
- Article
Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real‐world clinical experience.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1247, doi. 10.1111/hae.15086
- By:
- Publication type:
- Article
Acute neuromuscular and perceptual responses to blood flow restriction exercise in adults with severe haemophilia: A pilot study.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1193, doi. 10.1111/hae.15084
- By:
- Publication type:
- Article
Sexual functioning in men with haemophilia: Data from the haemophilia in the Netherlands‐6 study.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1243, doi. 10.1111/hae.15083
- By:
- Publication type:
- Article
Bioclinical features of haemophilia patients in Benin in 2023: Towards better care.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1210, doi. 10.1111/hae.15082
- By:
- Publication type:
- Article
Diagnosis and management of factor XI alloinhibitors in patients with congenital factor XI deficiency—A large single‐centre experience.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1155, doi. 10.1111/hae.15081
- By:
- Publication type:
- Article
Application of the PECARN head trauma rule to patients with haemophilia in the paediatric emergency department: A 15‐year retrospective study.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1238, doi. 10.1111/hae.15080
- By:
- Publication type:
- Article
Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1148, doi. 10.1111/hae.15079
- By:
- Publication type:
- Article
Review of interventions and effectiveness for heavy menstrual bleeding in women with moderate and severe von Willebrand disease.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1177, doi. 10.1111/hae.15078
- By:
- Publication type:
- Article
Multiyear, real‐world, retrospective cohort study using a patient‐centric approach to evaluate the burden of haemophilia B in the United States.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1234, doi. 10.1111/hae.15077
- By:
- Publication type:
- Article
Recombinant FVIII replacement products for haemophilia A: An updated valuation by indirect comparison measuring area under the curve.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1230, doi. 10.1111/hae.15076
- By:
- Publication type:
- Article
Real world management of individuals with severe FXI deficiency and its impact on clinical outcomes: Experience from a haemophilia treatment centre.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1164, doi. 10.1111/hae.15075
- By:
- Publication type:
- Article
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1138, doi. 10.1111/hae.15071
- By:
- Publication type:
- Article
Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1130, doi. 10.1111/hae.15037
- By:
- Publication type:
- Article
A case of bruising and joint hypermobility: The need to consider genetic testing for platelet disorders.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1225, doi. 10.1111/hae.15066
- By:
- Publication type:
- Article
A clinical practice guideline for primary care physiotherapy in patients with haemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1115, doi. 10.1111/hae.15065
- By:
- Publication type:
- Article
Evaluation of one‐stage and chromogenic assays for the laboratory measurement of factor VIII activity following valoctocogene roxaparvovec infusion.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1221, doi. 10.1111/hae.15064
- By:
- Publication type:
- Article
Low bleeding rates after intramuscular Covid‐19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1217, doi. 10.1111/hae.15063
- By:
- Publication type:
- Article
Emicizumab plasma levels after accelerated saturation in acquired haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1227, doi. 10.1111/hae.15069
- By:
- Publication type:
- Article
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A.
- Published in:
- Haemophilia, 2024, v. 30, n. 5, p. 1109, doi. 10.1111/hae.15031
- By:
- Publication type:
- Article